Eye Blood Flow Could Be Marker for Migraine
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 17, 2024 -- Blood flow appears to be reduced in the eye during migraine attacks, according to a study published online Nov. 30 in Headache: The Journal of Head and Face Pain.
Katherine Podraza, M.D., Ph.D., from the University of California, Los Angeles, and colleagues used optical coherence tomography angiography (OCTA) to determine if there are changes in structure and function of the retinal vasculature during and between migraine attacks. The analysis included 37 patients with migraine with aura (MA), 30 with migraine without aura (MO), and 20 healthy controls.
The researchers found a significant difference in the parafoveal vessel flux index (VFI) in the ictal state between the groups. There was a significant reduction in the parafoveal region VFI in MA during migraine attacks (−7 percent), as well as in MO (−7 percent) from their interictal baseline compared with controls. The MA group experienced a mean 13 percent lower blood perfusion interictally in the foveal region compared with the MO group. There was also higher circularity in the superficial foveal avascular zone in the MA group versus the MO group. Compared with the contralateral eye, patients with MA or MO and unilateral headache showed increased retinal vascular parameters consistent with greater perfusion in the eye ipsilateral to the side of the pain.
"These results indicate that changes in retinal perfusion could be a part of migraine pathophysiology, and that distinct retinal vascular signatures identified with OCTA could represent biomarkers for migraine," the authors write.
Several authors disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Atogepant Efficacious for Patients With Chronic Migraine
WEDNESDAY, June 26, 2024 -- For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27...
No Causal Association Seen for Meniere Disease, Migraine
MONDAY, June 3, 2024 -- Migraine is not a risk factor for Meniere disease (MD), nor is MD a risk factor for migraine, according to a study published online May 8 in Frontiers in...
Neighborhood Inequity Tied to More People Living With Vision Difficulty, Blindness
TUESDAY, May 14, 2024 -- Residential measures of inequity are associated with a greater number of individuals living with vision difficulty and blindness (VDB), according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.